ID

32475

Descrizione

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Keywords

  1. 02/11/18 02/11/18 -
  2. 30/11/18 30/11/18 -
Titolare del copyright

GSK group of companies

Caricato su

2 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Initial Serious Adverse Event Form

Randomisation
Descrizione

Randomisation

Did SAE occur after initiation of study medication?
Descrizione

Did SAE occur after initiation of study medication?

Tipo di dati

boolean

SAE Sequence Number
Descrizione

SAE Sequence Number

Tipo di dati

integer

Serious Adverse Event Entry
Descrizione

Serious Adverse Event Entry

Start Date
Descrizione

Start Date

Tipo di dati

date

Outcome
Descrizione

Outcome

Tipo di dati

text

End Date
Descrizione

if FATAL, Date of Death

Tipo di dati

date

Maximum Intensity
Descrizione

Maximum Intensity

Tipo di dati

text

Intensity at onset of event
Descrizione

Intensity at onset of event

Tipo di dati

text

Maximum Grade
Descrizione

Maximum Grade

Tipo di dati

text

Grade at onset of event
Descrizione

Grade at onset of event

Tipo di dati

text

Maximum Grade of Intensity
Descrizione

Record maximum grade or intensity throughout duration of event

Tipo di dati

text

Grade of Intensity at onset of event
Descrizione

Record grade of intensity at the onset of the event

Tipo di dati

text

Action taken with Investigational Product(s) as a result of AE?
Descrizione

Action taken with Investigational Product(s) as a result of AE?

Tipo di dati

text

Did the subject withdraw from the study as a result of AE?
Descrizione

Did the subject withdraw from the study as a result of AE?

Tipo di dati

boolean

Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descrizione

Use best judgement at initial entry. May be amended when additional information becomes available.

Tipo di dati

boolean

Duration of AE if < 24 hours
Descrizione

HH:MM

Tipo di dati

text

Time to Onset since last Dose
Descrizione

Time to Onset since last Dose

Tipo di dati

time

Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?
Descrizione

Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?

Tipo di dati

boolean

Was the event serious?
Descrizione

Was the event serious?

Tipo di dati

boolean

Related Investigational Product
Descrizione

Related Investigational Product

Tipo di dati

text

Seriousness
Descrizione

Seriousness

Level of seriousness of the event
Descrizione

Level of seriousness of the event

Tipo di dati

text

Relevant Concomitant/Treatment Medication
Descrizione

Relevant Concomitant/Treatment Medication

CM Sequence Number
Descrizione

Iclude any details of any medication that may help explain the SAE, may have caused the SAE or was used to treat the SAE.

Tipo di dati

text

Drug Name
Descrizione

Enter drug name, not description (Generic name preferred. If combination product, enter Trade Name).

Tipo di dati

text

Modified reported term
Descrizione

Modified reported term

Tipo di dati

text

Dose
Descrizione

Dose

Tipo di dati

float

Unit
Descrizione

Unit

Tipo di dati

text

Frequency
Descrizione

Frequency

Tipo di dati

text

Route
Descrizione

Route

Tipo di dati

text

Start Date
Descrizione

Start Date

Tipo di dati

date

Ongoing?
Descrizione

Ongoing?

Tipo di dati

boolean

If NO, specify End Date
Descrizione

If NO, specify End Date

Tipo di dati

date

Primary Indication
Descrizione

Enter a medical diagnosis not description

Tipo di dati

text

Modified reported term
Descrizione

Modified reported term

Tipo di dati

text

Drug Type
Descrizione

Drug Type

Tipo di dati

text

Relevant Medical Conditions/Risk Factors
Descrizione

Relevant Medical Conditions/Risk Factors

MHx Sequence Number
Descrizione

MHx Sequence Number

Tipo di dati

text

Specific Condition Name
Descrizione

Enter a medical diagnosis not description.

Tipo di dati

text

Modified reported term
Descrizione

Modified reported term

Tipo di dati

text

Date of onset
Descrizione

Date of onset

Tipo di dati

date

Continuing?
Descrizione

Continuing?

Tipo di dati

text

If NO, specify date of last occurrence
Descrizione

If NO, specify date of last occurrence

Tipo di dati

date

Relevant Diagnosis Results
Descrizione

Relevant Diagnosis Results

Lab Sequence Number
Descrizione

Provide details of any tests or procedures carried out to diagnose the SAE.

Tipo di dati

text

Test Name
Descrizione

Test Name

Tipo di dati

text

Test Date
Descrizione

Test Date

Tipo di dati

date

Test Result
Descrizione

Test Result

Tipo di dati

text

Test Units
Descrizione

Test Units

Tipo di dati

text

Normal Low Range
Descrizione

Normal Low Range

Tipo di dati

integer

Normal High Range
Descrizione

Normal High Range

Tipo di dati

integer

Relevant diagnostic results not noted above
Descrizione

Relevant diagnostic results not noted above

Tipo di dati

text

Rechallenge
Descrizione

Rechallenge

If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
Descrizione

If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?

Tipo di dati

text

Investigational Product
Descrizione

Investigational Product

Study Drug
Descrizione

Study Drug

Tipo di dati

text

Start Date
Descrizione

Start Date

Tipo di dati

date

Stop Date
Descrizione

Stop Date

Tipo di dati

date

Regimen
Descrizione

Regimen

Tipo di dati

text

General narrative comments
Descrizione

General narrative comments

A brief narrative description of SAE
Descrizione

possible other causes of the event (e.g., lack of efficacy, withdrawal of investigational product, the disease under study or other medical conditions) and details of treatment.

Tipo di dati

text

Non Clinical
Descrizione

Non Clinical

Send incomplete SAE data to GSK Safety
Descrizione

Send incomplete SAE data to GSK Safety

Tipo di dati

text

Receipt by GSK date
Descrizione

Receipt by GSK date

Tipo di dati

date

Was the event serious?
Descrizione

Was the event serious?

Tipo di dati

boolean

SAE Sequence number
Descrizione

SAE Sequence number

Tipo di dati

text

Version Number
Descrizione

Version Number

Tipo di dati

text

Case ID
Descrizione

Case ID

Tipo di dati

text

Randomisation Number
Descrizione

Randomisation Number

Tipo di dati

text

OCEANS Code
Descrizione

OCEANS Code

Tipo di dati

text

Similar models

Initial Serious Adverse Event Form

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Randomisation
Did SAE occur after initiation of study medication?
Item
Did SAE occur after initiation of study medication?
boolean
SAE Sequence Number
Item
SAE Sequence Number
integer
Item Group
Serious Adverse Event Entry
Start Date
Item
Start Date
date
Item
Outcome
text
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/not resolved (3)
CL Item
Recovered/Resolved with sequelae  (4)
CL Item
Fatal (5)
End Date
Item
End Date
date
Item
Maximum Intensity
text
Code List
Maximum Intensity
CL Item
[1] Mild (1)
CL Item
[2] Moderate (2)
CL Item
[3] Severe (3)
CL Item
[x] Not applicable (4)
Item
Intensity at onset of event
text
Code List
Intensity at onset of event
CL Item
[1] Mild (1)
CL Item
[2] Moderate (2)
CL Item
[3] Severe (3)
CL Item
[x] Not applicable (4)
Item
Maximum Grade
text
Code List
Maximum Grade
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
Item
Grade at onset of event
text
Code List
Grade at onset of event
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
Item
Maximum Grade of Intensity
text
Code List
Maximum Grade of Intensity
CL Item
Mild or Grade 1 (1)
CL Item
Moderate or Grade 2 (2)
CL Item
Severe or Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
CL Item
Not applicable (6)
Item
Grade of Intensity at onset of event
text
Code List
Grade of Intensity at onset of event
CL Item
Mild or Grade 1 (1)
CL Item
Moderate or Grade 2 (2)
CL Item
Severe or Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
CL Item
Not applicable (6)
Item
Action taken with Investigational Product(s) as a result of AE?
text
Code List
Action taken with Investigational Product(s) as a result of AE?
CL Item
Investigational product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (6)
Did the subject withdraw from the study as a result of AE?
Item
Did the subject withdraw from the study as a result of AE?
boolean
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
Duration of AE if < 24 hours
Item
Duration of AE if < 24 hours
text
Time to Onset since last Dose
Item
Time to Onset since last Dose
time
Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?
Item
Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?
boolean
Was the event serious?
Item
Was the event serious?
boolean
Related Investigational Product
Item
Related Investigational Product
text
Item Group
Seriousness
Item
Level of seriousness of the event
text
Code List
Level of seriousness of the event
CL Item
results in death (1)
CL Item
is life threatening (2)
CL Item
requires hospitalisation or prolongation of existing hospitalisation  (3)
CL Item
results in disability/incapacity (4)
CL Item
congenital anomaly/birth defect (5)
CL Item
other, specify within general narrative comment (6)
Item Group
Relevant Concomitant/Treatment Medication
CM Sequence Number
Item
CM Sequence Number
text
Drug Name
Item
Drug Name
text
Modified reported term
Item
Modified reported term
text
Dose
Item
Dose
float
Unit
Item
Unit
text
Frequency
Item
Frequency
text
Route
Item
Route
text
Start Date
Item
Start Date
date
Ongoing?
Item
boolean
If NO, specify End Date
Item
If NO, specify End Date
date
Primary Indication
Item
Primary Indication
text
Modified reported term
Item
Modified reported term
text
Drug Type
Item
Drug Type
text
Item Group
Relevant Medical Conditions/Risk Factors
MHx Sequence Number
Item
MHx Sequence Number
text
Specific Condition Name
Item
Specific Condition Name
text
Modified reported term
Item
Modified reported term
text
Date of onset
Item
Date of onset
date
Item
Continuing?
text
Code List
Continuing?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
If NO, specify date of last occurrence
Item
If NO, specify date of last occurrence
date
Item Group
Relevant Diagnosis Results
Lab Sequence Number
Item
Lab Sequence Number
text
Test Name
Item
Test Name
text
Test Date
Item
Test Date
date
Test Result
Item
Test Result
text
Test Units
Item
Test Units
text
Normal Low Range
Item
Normal Low Range
integer
Normal High Range
Item
Normal High Range
integer
Relevant diagnostic results not noted above
Item
text
Item Group
Rechallenge
Item
If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
text
Code List
If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
CL Item
No (1)
CL Item
Yes (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item Group
Investigational Product
Item
Study Drug
text
Code List
Study Drug
CL Item
Novel dry powder inhaler (1)
Start Date
Item
Start Date
date
Stop Date
Item
Stop Date
date
Regimen
Item
Regimen
text
Item Group
General narrative comments
A brief narrative description of SAE
Item
A brief narrative description of SAE
text
Item Group
Non Clinical
Send incomplete SAE data to GSK Safety
Item
Send incomplete SAE data to GSK Safety
text
Receipt by GSK date
Item
Receipt by GSK date
date
Was the event serious?
Item
Was the event serious?
boolean
SAE Sequence number
Item
SAE Sequence number
text
Version Number
Item
Version Number
text
Case ID
Item
Case ID
text
Randomisation Number
Item
Randomisation Number
text
OCEANS Code
Item
OCEANS Code
text

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial